Description

Functional pathway analysis of the gut microbiome in IBS-D participants following probiotic intervention with Lactiplantibacillus plantarum GTB1. Predicted metabolic pathways indicate potential mechanisms through which the probiotic influences intestinal function.

Figure 13

Chart

Source Paper

Effect of Oral Intake of Lactiplantibacillus plantarum APsulloc 331261 (GTB1TM) on Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study.

Nutrients (2022)

PMID: 35631156

DOI: 10.3390/nu14102015

Cite This Figure

![Figure 13: Functional pathway analysis of the gut microbiome in IBS-D participants following probiotic intervention with Lactiplantibacillus plantarum GTB1. Predicted metabolic pathways indicate potential mechanisms through which the probiotic influences intestinal function.]()

> Source: Kyoungmi Jung et al. "Effect of Oral Intake of Lactiplantibacillus plantarum APsulloc 331261 (GTB1TM) ." *Nutrients*, 2022. PMID: [35631156](https://pubmed.ncbi.nlm.nih.gov/35631156/)

<figure>
  <img src="" alt="Functional pathway analysis of the gut microbiome in IBS-D participants following probiotic intervention with Lactiplantibacillus plantarum GTB1. Predicted metabolic pathways indicate potential mechanisms through which the probiotic influences intestinal function." />
  <figcaption>Figure 13. Functional pathway analysis of the gut microbiome in IBS-D participants following probiotic intervention with Lactiplantibacillus plantarum GTB1. Predicted metabolic pathways indicate potential mechanisms through which the probiotic influences intestinal function.<br>  Source: Kyoungmi Jung et al. "Effect of Oral Intake of Lactiplantibacillus plantarum APsulloc 331261 (GTB1TM) ." <em>Nutrients</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35631156/">35631156</a></figcaption>
</figure>

Related Evidence

Lactobacillus plantarum for Irritable Bowel Syndrome (IBS)

Grade B · 5 studies